Dall'Era M - Search Results

1

Disulfide-crosslinked nanomicelles confer cancer-specific drug delivery and improve efficacy of paclitaxel in bladder cancer.

Pan A, Zhang H, Li Y, Lin TY, Wang F, Lee J, Cheng M, Dall'Era M, Li T, deVere White R, Pan CX, Lam KS. Pan A, et al. Nanotechnology. 2016 Oct 21;27(42):425103. doi: 10.1088/0957-4484/27/42/425103. Epub 2016 Sep 19. Nanotechnology. 2016. PMID: 27640312 Free PMC article.

2

Contemporary management of muscle-invasive bladder cancer.

Dall'Era MA, Cheng L, Pan CX. Dall'Era MA, et al. Expert Rev Anticancer Ther. 2012 Jul;12(7):941-50. doi: 10.1586/era.12.60. Expert Rev Anticancer Ther. 2012. PMID: 22845409 Free PMC article. Review.

3

No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period.

Wu JN, Fish KM, Evans CP, Devere White RW, Dall'Era MA. Wu JN, et al. Cancer. 2014 Mar 15;120(6):818-23. doi: 10.1002/cncr.28485. Epub 2013 Nov 20. Cancer. 2014. PMID: 24258693 Free article.

4

Nanotechnology in bladder cancer: current state of development and clinical practice.

Tomlinson B, Lin TY, Dall'Era M, Pan CX. Tomlinson B, et al. Nanomedicine (Lond). 2015;10(7):1189-201. doi: 10.2217/nnm.14.212. Nanomedicine (Lond). 2015. PMID: 25929573 Free PMC article. Review.

5

A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer.

Chow H, Ghosh PM, deVere White R, Evans CP, Dall'Era MA, Yap SA, Li Y, Beckett LA, Lara PN Jr, Pan CX. Chow H, et al. Cancer. 2016 Jun 15;122(12):1897-904. doi: 10.1002/cncr.29927. Epub 2016 Mar 28. Cancer. 2016. PMID: 27019001 Free PMC article. Clinical Trial.

6

Effect of Neoadjuvant Chemotherapy on Renal Function following Radical Cystectomy: Is there a Meaningful Impact?

Chandrasekar T, Pugashetti N, Durbin-Johnson B, Dall'Era MA, Evans CP, deVere White RW, Yap SA. Chandrasekar T, et al. Bladder Cancer. 2016 Oct 27;2(4):441-448. doi: 10.3233/BLC-160071. Bladder Cancer. 2016. PMID: 28035325 Free PMC article.

7

Microchamber Cultures of Bladder Cancer: A Platform for Characterizing Drug Responsiveness and Resistance in PDX and Primary Cancer Cells.

Gheibi P, Zeng S, Son KJ, Vu T, Ma AH, Dall'Era MA, Yap SA, de Vere White RW, Pan CX, Revzin A. Gheibi P, et al. Sci Rep. 2017 Sep 25;7(1):12277. doi: 10.1038/s41598-017-12543-9. Sci Rep. 2017. PMID: 28947782 Free PMC article.

8

Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.

Dall'Era MA, deVere-White R, Rodriguez D, Cress R. Dall'Era MA, et al. Eur Urol Focus. 2019 Nov;5(6):1014-1021. doi: 10.1016/j.euf.2018.04.016. Epub 2018 May 4. Eur Urol Focus. 2019. PMID: 29735368

9

New Insights into Ejaculatory Frequency and Prostate Cancer Risk: Association, Causation, or What Do We Have to Lose?

Dall'Era MA, De Vere White RW. Dall'Era MA, et al. Eur Urol. 2018 Nov;74(5):549-550. doi: 10.1016/j.eururo.2018.08.014. Epub 2018 Sep 1. Eur Urol. 2018. PMID: 30177292 No abstract available.

10

Framing Pragmatic Strategies to Reduce Mortality From Bladder Cancer: An Endorsement From the Society of Urologic Oncology.

de Vere White R, Lara PN Jr, Black PC, Evans CP, Dall'Era M. de Vere White R, et al. J Clin Oncol. 2020 Jun 1;38(16):1760-1762. doi: 10.1200/JCO.19.01731. Epub 2020 Jan 17. J Clin Oncol. 2020. PMID: 31951493 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters